H1B Report
Side-by-side comparison

Institute for Cancer Research vs Microsoft Corporation

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Institute for Cancer Research
PARank #FEIN 23-6296135
Entity B
Microsoft Corporation
WARank #5FEIN 91-1144442

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricInstitute for Cancer Research Microsoft Corporation
Total filings14172,912
Certified %82.98%94.30%
Denied %9.22%0.15%
Withdrawn %0.00%0.69%
Cert-withdrawn %7.80%4.85%
Rank#5
Active yearsFY2012–FY2026FY2010–FY2026
Worksite statePAWA

Outcomes — Institute for Cancer Research

DOL case-status mix.

Outcome breakdown: Certified 83.0%, Cert-withdrawn 7.8%, Denied 9.2%
Outcome breakdown
OutcomeShare
Certified83.0%
Cert-withdrawn7.8%
Denied9.2%
Certified83.0%
Cert-withdrawn7.8%
Denied9.2%

Outcomes — Microsoft Corporation

DOL case-status mix.

Outcome breakdown: Certified 94.3%, Cert-withdrawn 4.9%, Withdrawn 0.7%, Denied 0.2%
Outcome breakdown
OutcomeShare
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%
Certified94.3%
Cert-withdrawn4.9%
Withdrawn0.7%
Denied0.2%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Institute for Cancer Research
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY201211
FY201323
FY201411
FY20159
FY20165
FY201717
FY201814
FY201915
FY20201
FY20210
FY20220
FY20230
FY202415
FY202512
FY20268
Microsoft Corporation
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20104,407
FY20114,184
FY20124,005
FY20133,832
FY20143,674
FY20154,476
FY20164,919
FY20174,884
FY20185,457
FY20196,000
FY202051
FY2021110
FY2022150
FY20232,791
FY20249,492
FY20259,362
FY20265,118

Top 5 occupations — Institute for Cancer Research

Top 5 occupations — Microsoft Corporation

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.